Publications:

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC.

Therapeutic Advances In Medical Oncology

Cinausero, Marika M; Laprovitera, Noemi N; De Maglio, Giovanna G; Gerratana, Lorenzo L; Riefolo, Mattia M; Macerelli, Marianna M; Fiorentino, Michelangelo M; Porcellini, Elisa E; Buoro, Vanessa V; Gelsomino, Francesco F; Squadrilli, Anna A; Fasola, Gianpiero G; Negrini, Massimo M; Tiseo, Marcello M; Ferracin, Manuela M; Ardizzoni, Andrea A

Publication Date: 2019

Variant appearance in text: TP53: I195_R196del

PubMed Link: 31798692

Variant Present in the following documents:

• Main text
• 10.1177_1758835919885540.pdf

View BVdb publication page